Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05368506
Title ZN-c3 for the Treatment of Metastatic Triple-Negative Breast Cancer and Advanced Ovarian Cancer
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors OHSU Knight Cancer Institute
Indications

triple-receptor negative breast cancer

peritoneum cancer

ovarian cancer

fallopian tube cancer

Therapies

ZN-c3

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.